What long‑lasting peritoneal drainage option is recommended for a patient with recurrent or refractory ascites who is not a candidate for TIPS or liver transplantation, and how should the catheter be placed, managed, and what precautions are needed?

Long-Lasting Peritoneal Drainage for Refractory Ascites

Serial large-volume paracentesis remains the standard of care for refractory ascites in patients not eligible for TIPS or transplantation, while long-term indwelling peritoneal catheters should only be considered in highly selected cases as a palliative measure, not as standard therapy. 1, 2

Standard Management Approach

The most recent high-quality guidelines consistently recommend serial large-volume paracentesis (LVP) as first-line treatment for refractory ascites when TIPS and transplantation are not options 1, 2. This approach:

• Requires patients to come to hospital every few weeks for temporary drain insertion
• Mandates albumin infusion of 6-8 g per liter of ascites removed when >5L is drained 1
• Should be combined with continued low-salt diet (≤5g/day) 1
• Allows for careful monitoring of complications

Long-Term Indwelling Catheters: Current Evidence

The safety and efficacy of permanent indwelling peritoneal catheters have NOT been clearly demonstrated in cirrhosis-induced ascites 1. The most recent 2021 Gut guidelines explicitly state that "alternative treatments for untreatable ascites, such as long-term abdominal drains, need further research" 2.

When to Consider (Exceptional Circumstances Only):

Long-term tunneled peritoneal catheters may be considered only for:

• Patients with poor access to serial LVP (geographic, mobility issues) 1
• Those with abdominal wounds limiting serial LVP 1
• Palliative care situations where quality of life outweighs infection risk 2
• Patients requiring arrangements with "robust clinical governance, audit or research" 2

Critical Precautions and Complications:

The infection risk is substantial and must be weighed carefully:

• Average bacterial infection rate of 13% in published studies 3
• Bacterial peritonitis occurs in a significant proportion of patients 4, 5
• Catheter colonization is nearly universal (all patients in one study) 5
• Most common organism: Staphylococcus epidermidis 5
• Longer catheter dwell time significantly increases infection risk 6
• Additional complications include leakage at insertion site, catheter dislodgement, and obstruction 4, 6

Catheter Placement and Management Protocol:

If proceeding with tunneled catheter placement (e.g., PleurX catheter):

Placement:

• Ultrasound and fluoroscopy-guided insertion 6
• Technical success rate approaches 100% 4, 6
• Should be performed by experienced interventional radiologists or trained specialists

Management:

• Home-based drainage typically 1-2 liters daily 7
• Reduces need for hospital paracentesis from 2.2 per week to zero 7
• Allows reduction in diuretic dosing 7
• Requires patient/caregiver education on sterile technique
• Close monitoring for signs of infection (fever, abdominal pain, cloudy fluid)
• Regular follow-up with hepatology team

Monitoring:

• Serial assessment of renal function, electrolytes, and albumin 7
• Prompt evaluation of any signs of infection
• Consider prophylactic antibiotics (though evidence is limited in cirrhosis)

Alternative Experimental Options

Other devices mentioned in guidelines but not recommended as standard:

• Alfapump (automated low-flow ascites pump): Drains ascites into bladder, improves quality of life but causes AKI; not available in North America 3, 2
• Peritoneovenous shunt: Many complications, no survival benefit over medical treatment; only for extreme cases 1, 8, 1

Critical Clinical Pitfall

Do not use indwelling catheters as routine management. The 2021 Gut guidelines and 2021 AASLD guidance emphasize these devices cannot be regarded as standard of care 2, 3. The risk-benefit ratio remains uncertain, particularly for Child-Pugh C patients 3.

Definitive Recommendation Algorithm

1. First priority: Evaluate for liver transplantation (all patients with refractory ascites) 1
2. Second priority: Assess TIPS candidacy (if MELD <18, age <70, bilirubin <50 μmol/L) 2, 3
3. Standard therapy: Serial LVP with albumin replacement 1, 2, 1
4. Only if LVP access impossible or palliative care focus: Consider tunneled catheter with full informed consent about infection risks 2, 9

The evidence strongly favors repeated hospital-based paracentesis over permanent catheters for morbidity and mortality outcomes in cirrhotic ascites.